Companies / Santa Cruz Biotechnology / SATB2 (SATBA4B10)
Santa Cruz Biotechnology

SATB2 (SATBA4B10) | Santa Cruz Biotechnology

mouse monoclonal IgG1; SATB2 Antibody (SATBA4B10) is an IgG1 κ mouse monoclonal SATB2 antibody (also designated Special AT-Rich Sequence-Binding Protein 2 antibody, DNA-Binding Protein SATB2 antibody, or SATB Family Member 2 antibody) that detects the SATB2 protein of mouse, rat and human origin by WB, IP and IF. SATB2 Antibody (SATBA4B10) is available as the non-conjugated anti-SATB2 antibody. SATB2 (Special AT-rich sequence-binding protein 2) is a nuclear matrix protein that influences craniofacial formation mechanisms, such as jaw and palate development, and is part of a transcriptional network regulating skeletal development and osteoblast differentiation. Highly expressed in adult and fetal brain, SATB2 contains two CUT DNA-binding domains and one homeobox domain and is closely related to SATB1, a transcriptional repressor. SATB2 is thought to bind to matrix-attachment regions (MARs) and regulate MAR-dependent transcription of various genes, including HoxA2 and ATF4 (CREB-2), involved in skeletal development. Functioning as both a transcriptional activator and repressor, SATB2 can also act as a protein scaffold that can enhance the activity of other DNA-binding proteins. Defects in the gene encoding SATB2 are the cause of cleft palate manifested in conjunction with severe mental retardation.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.